IntelliCell BioSciences Issues Corrected Listing For Human Cells, Tissues, and Cellular Based Products
PR Newswire (Thu, Nov. 15, 2012)INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Change in Directors or Prin
PR Newswire (Thu, Nov. 8, 2012)IntelliCell BioSciences Announces FDA Listing For Human Cells, Tissues, and Cellular Based Products
PR Newswire (Thu, Nov. 8, 2012)IntelliCell BioSciences Announces Myron Z. Holubiak Joins the IntelliCell BioSciences Board of Directors
PR Newswire (Mon, Oct. 29, 2012)IntelliCell BioSciences Announces the Manufacture of Stromal Vascular Fraction Cells from Non-Living Donated Adipose Tissue
PR Newswire (Tues, Oct. 9, 2012)IntelliCell Announces Research Tissue Bank License
PR Newswire (Thurs, Oct. 4, 2012)IntelliCell BioSciences Announces Clinical Study For Diabetic Critical Limb Ischemia
PR Newswire (Thurs, Sep. 13, 2012)INTELLICELL BIOSCIENCES, INC. Financials
EDGAR Online Financials (Sat, Aug 25, 2012)INTELLICELL BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Aug 21, 2012)IntelliCell BioSciences, Inc. New Lab at 460 Park Avenue, New York, NY is cGTP Compliant
PR Newswire (Tue, July 24, 2012)IntelliCell BioSciences Files Patent Application for a New Research Technique
PR Newswire (Mon, July 23, 2012)IntelliCell Opens New Flagship Medical Facility
PR Newswire (Tue, June 4, 2012)IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair Research
PR Newswire (Tue, May 22, 2012)INTELLICELL BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, May 21, 2012)INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
EDGAR Online (Fri, May 18, 2012)IntelliCell BioSciences Announces Frederick Frank as Executive Advisor to Board of Directors
PR Newswire (Fri, May 10, 2012)INTELLICELL BIOSCIENCES, INC. Financials
EDGAR Online Financials (Thu, April 26, 2012)INTELLICELL BIOSCIENCES, INC. Files SEC form 10-K/A, Annual Report
EDGAR Online (Mon, April 23, 2012)INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an
EDGAR Online (Thu, April 19, 2012)INTELLICELL BIOSCIENCES, INC. Files SEC form 10-K, Annual Report
EDGAR Online (Wed, April 18, 2012)IntelliCell BioSciences Expands Management Team
PR Newswire (Thu, April 12, 2012)INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an
EDGAR Online (Wed, April 11, 2012)IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
PR Newswire (Tue, April 10, 2012)INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Apr 3, 2012)IntelliCell BioSciences, Inc. to Address FDA Warning Letter
PR Newswire (Wed, March 28, 2012)INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Wed, March 14, 2012)IntelliCell Presents at Roth Conference March 14th
Business Wire (Tue, March 13)INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities
EDGAR Online (Thu, Feb 23)IntelliCell BioScience Inc. Procedure Enables Norwegian Star Basketball Player to Fully Recover from Patella Tendinitis to Play for Manhattan College
Business Wire (Tue, Feb 21)IntelliCell Demonstrates at the American Sports Medicine Institute Held in Conjunction with and at the Andrews Sports Medicine & Orthopedic Center in Birmingham, AL
Business Wire (Tue, Feb 7)INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events, Financial Sta
EDGAR Online (Fri, Feb 3)IntelliCell Filed Patent Application for its Proprietary Method of Manufacturing Stromal Vascular Fraction Cells
Business Wire (Thu, Jan 26)IntelliCell Demonstrates at the American Sports Medicine Institute Held in Conjunction with and at the Andrews Sports Medicine & Orthopedic Center in Birmingham, AL
Business Wire - Tuesday, Feb 7, 2012 (9:18AM EST)INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events, Financial Sta
EDGAR Online - Friday, Feb 3, 2012 (10:00AM EST)IntelliCell Filed Patent Application for its Proprietary Method of Manufacturing Stromal Vascular Fraction Cells
Business Wire - Thursday, Jan 26, 2012 (9:12AM EST)INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online - Wednesday, Jan 25, 2012 (2:42PM EST)IntelliCell Filed Patent Application for its Proprietary Method of Manufacturing Stromal Vascular Fraction Cells
Business Wire - Thursday, Jan 12, 2012 (9:12AM EST)IntelliCell BioSciences Announces the Licensing of its Proprietary Patent, Pending Stomal Vascular Manufacturing Technology to IntelliCell BioSciences of Canada
Business Wire - Wednesday, Jan 11, 2012 (9:04AM EST)INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online - Tuesday, Jan 10, 2012Intellicell Biosciences announces the licensing of its proprietary patent, pending stromal vascular fraction manufacturing technology
Business Wire - Tuesday, Jan 10, 2012CORRECTING and REPLACING IntelliCell Biosciences Inc. Announces the Addition of World Renowned Orthopedic Surgeons and Sports Medicine Doctors to Medical Advisory Board
Business Wire - Monday, Jan 9, 2012 (2:42PM EST)IntelliCell Biosciences Inc. Announces the Addition of World Renowned Orthopedic Surgeons and Sports Medicine Doctors to Medical Advisory Board
Business Wire - Monday, Jan 9, 2012 (2:42PM EST)IntelliCell Biosciences Presents at BioTech Showcase Conference January 9, 2012
NEW YORK, NY--(Business Wire)--(January 5, 2012) - IntelliCell Biosciences, Inc. (OTCQB: SVFC.PK - News) (PINKSHEETS: SVFC.PK - News); ("IntelliCell") or the ("Company"), Dr. Steven Victor, Chairman of IntelliCell Biosciences will be presenting at the BioTech Showcase Conference on January 9, 2012 at 11:30 a.m. (PT). Parc 55 Wyndham San Francisco - Union 55 Cyril Magnin Street San Francisco, CA 94102 Admission Room #2.
Thu, Jan 5, 2012 1:58 PM
IntelliCell Biosciences Presents at BioTech Showcase Conference January 9, 2012
NEW YORK, NY--(Business Wire)--(January 5, 2012) - IntelliCell Biosciences, Inc. (OTCQB: SVFC.PK - News) (PINKSHEETS: SVFC.PK - News); ("IntelliCell") or the ("Company"), Dr. Steven Victor, Chairman of IntelliCell Biosciences will be presenting at the BioTech Showcase Conference on January 9, 2012 at 11:30 a.m. (PT). Parc 55 Wyndham San Francisco - Union 55 Cyril Magnin Street San Francisco, CA 94102 Admission Room #2.
Thu, Jan 5, 2012 1:58 PM
INTELLICELL BIOSCIENCES, INC. Financials
EDGAR Online Financials - Thursday, Dec 22, 2011INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Completion of Acquisi
EDGAR Online - Wednesday, Dec 21, 2011IntelliCell BioSciences Inc. Announces James R. Andrews, M.D. Has Joined Its Medical Advisory Board
Business Wire - Wednesday, Dec 21, 2011INTELLICELL BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online - Monday, Dec 19, 2011IntelliCell BioSciences, Inc Announces Powerful Collaboration with Numoda Corporation
Business Wire - Tuesday, Dec 13, 2011INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Completion of Acquisi
EDGAR Online - Wednesday, Dec 7, 2011Other Stem Cell Players Ready To Fill Void Left By Geron
Seeking Alpha - Wednesday, Nov 16, 2011INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K/A, Unregistered Sale of Equity Securities, Amendments to Articles of
EDGAR Online - Monday, Oct 31, 2011INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Amendments to Articles of
IEDGAR Online - Thursday, Oct 27, 2011IntelliCell BioSciences Announces Study Published in The Journal of Implant & Advanced Clinical Dentistry
Marketwire - Wednesday, Oct 20, 2011INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Completion of Acquisi
EDGAR Online - Monday, Oct 19, 2011IntelliCell BioSciences, Inc. Appoints Jack Schneider to Its Board of Advisors
Marketwire - Monday, Oct 19, 2011IntelliCell BioSciences Out to Shake Up Regenerative Medicine With Disruptive Technology and Game Plan
Marketwire - Wednesday, Sep 28, 2011IntelliCell BioSciences, Inc. Announces It Has Signed an Exclusive Supply and Sale Agreement With Millipore Corporation
Marketwire - Monday, Sep 26, 2011IntelliCell BioSciences, Inc. Announces It Will Present at the Rodman & Renshaw Annual Global Investment Summit in New York
Marketwire - Monday, Sep 12, 2011INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an
EDGAR Online - Friday, Sep 2, 2011IntelliCell BioSciences, Inc. Announces It Has Signed a Licensing Agreement With The PAWS Pet Company, Inc.
Marketwire - Tuesday, Aug 30, 2011The PAWS Pet Company and IntelliCell BioSciences to Bring Regenerative Cell Therapy to Animals
Marketwire - Tuesday, Aug 30, 2011Human Body's Fat Seen As best Source of Stem Cells For Regenerative Therapies
Forbes - Sunday, Aug 28, 2011INTELLICELL BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online - Monday, Aug 22, 2011INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial Statemen
EDGAR Online - Thursday, Aug 18, 2011INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements
EDGAR Online - Tuesday, Aug 16, 2011INTELLICELL BIOSCIENCES, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Completion of Acquisi
EDGAR Online - Thursday, Aug 11, 2011IntelliCell BioSciences, Inc. Announces It Will Open Adipose Tissue Processing Center in Baton Rouge
Marketwire - Thursday, Aug 4, 2011IntelliCell BioSciences, Inc. Announces It Will Open Adipose Tissue Processing Center in Orlando
NEW YORK, NY--(Aug 3, 2011) - IntelliCell BioSciences, Inc. ( OTCQB : SVFC ) ( PINKSHEETS : SVFC ) ("IntelliCell" or the "Company"), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult ...
8/3/2011 11:11:05 AM
IntelliCell BioSciences, Inc. Announces It Will Open Adipose Tissue Processing Center in Houston
NEW YORK, NY--(Aug 1, 2011) - IntelliCell BioSciences, Inc. ( OTCQB : SVFC ) ( PINKSHEETS : SVFC ) ("IntelliCell" or the "Company"), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult ...
8/1/2011 11:45:36 AM
IntelliCell BioSciences, Inc. Announces It Will Open Adipose Tissue Processing Center in Denver
NEW YORK, NY--(July 28, 2011) - IntelliCell BioSciences, Inc. ( OTCQB : SVFC ) ( PINKSHEETS : SVFC ) ("IntelliCell" or the "Company"), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult...
7/28/2011 11:54:56 AM
IntelliCell BioSciences' Stem Cell Technology Validated by Merck Subsidiary
NEW YORK, NY--(Jul 14, 2011) - IntelliCell BioSciences, Inc. ( OTCQB : SVFC ) ( PINKSHEETS : SVFC ) ("IntelliCell" or the "Company"), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult ...
7/14/2011 7:00:00 AM
IntelliCell BioSciences, Inc. Announces Name Change From Media Exchange Group, Inc. and New Trading Symbol "SVFC"
NEW YORK, NY--(July 7, 2011) - IntelliCell BioSciences, Inc. ( OTCQB : SVFC ) ( PINKSHEETS : SVFC ) and formerly ( OTCQB : CWLC ) ( PINKSHEETS : CWLC ) ("IntelliCell" or the "Company"), a leader in regenerative medicine and the manufacturing of stromal vasc...
7/7/2011 7:00:00 AM
Intellicell™ Facts:
IntelliCell™ technology process yields stromal vascular fraction which is a functionally diverse cell population of cells that it is believed to be synergistic and able to communicate with other cells in their local environment. The mechanism of action of the stromal vascular fraction which we have branded as "IntelliCell™" is more than regenerative. More >
Intellicell™ Clinical Studies:
IntelliCell™ is focused on areas in medicine with high unmet clinical needs. Our planned clinical studies include autologous cellular treatments for osteoarthritis, gingival gum regeneration, sports medicine injuries, and multiple sclerosis. The Company is planning to work with well respected clinical investigators in the fields of orthopedics, orthodontics, and internal medicine. Our objective is to take a leadership role in the development of ethical and safe products for regenerative medicine. More >